Recently diagnosed with HIV? Click here

HIV treatments

Displayed below is content from the NAPWA website tagged with the keyword HIV treatments.

Key resources

Cover image - Managing Side Effects booklet

This booklet is for people with HIV who experience side effects from HIV treatments or other physical symptoms that may be due to HIV infection. It will help you identify side effects, and provides suggestions on how to prevent, manage, reduce or eliminate some common side effects.

Getting the best HIV care (cover image)

NAPWA has produced this guide to help HIV-positive Australians make the best decisions they can about their health, care and treatment.

Clinical Trials

Resource • 1 July 2004

This fact sheet provides you with information and some questions to ask if you are considering participating in a clinical trialA clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase IA clinical trial designed to establish whether an experimental drug is safe for humans to take. Phase I studies determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and look for early evidence of effectiveness; these studies may include either people with HIV, HIV-negative volunteers, or both tests a new drug or treatment in a small group; Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. expands the study to a larger group of people; Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. expands the study to an even larger group of people; and Phase IVPost-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use. takes place after the drug or treatment has been licensed and marketed. read more »

Lower dose darunavir better all round

Positive Living article • Adrian Ogier • 24 November 2011

A new, once-daily, lower dose of the protease inhibitorA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate. darunavir (Prezista) is available on the PBS[Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. from 1 December.

To date, the recommended dose has been 600mg taken twice-a-day along with 100mg of ritonavir. But this new daily dose is just 800mg boosted with a single dose of ritonavir.

The lower dosage of both drugs appears to have a much better side effectAn unwanted effect caused by the administration of drugs. Onset may be sudden or develop over time. profile. read more »

New trial needs volunteers

Positive Living article • Adrian Ogier • 24 November 2011
Defeating HIV

At the conference, Julian Elliot from The Burnet Institute in Melbourne spoke of our ‘combo-prevention future’, where a successful vaccine and cure could potentially end the epidemic. read more »

Rilpivirine as good as efavirenz

Positive Living article • David Menadue • 24 November 2011

Dr Mark Bloch from Holdsworth House in Sydney presented the 48-week results of the combined ECHO and THRIVE studies which determined that the new NNRTI rilpivirine (RPV) is as effective as efavirenz (EFV) for first-line treatment.

Everyone in the studies received a nucleoside backbone to their treatment – in ECHO it was Truvada, in THRIVE it was tenfovir/3TC or abacavir/3TC. read more »

Consumer Guide to Clinical Trials released

Story • Consumers Health Forum of Australia • 15 September 2011

The Clinical Trials Action Group (CTAG) was established in October 2009 to identify and progress necessary reforms to secure Australia’s competitiveness in the clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trials sector.

Following the release of the CTAG's report, the Consumers Health Forum was funded by the Department of Innovation, Industry, Science and Research to develop a factsheet to provide consumer-friendly information about clinical trials, in response to a recommendation for improved consumer access to information on clinical trials. read more »

New treatment briefs

Positive Living article • Adrian Ogier • 1 September 2011

Adrian Ogier gives the low-down on latest antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatments. read more »

Tenofovir vs abacavir: the saga continues

Positive Living article • Adrian Ogier • 1 September 2011

Compared to abacavir, tenofovir does increase bone mineral density (BMD) loss but not fracture risk, according to the results from the STEAL trial reported at the IAS Conference in Rome. read more »

Prolonged process for approved drugs

Positive Living article • Adrian Ogier • 26 May 2011

The government caused turmoil by announcing in February that all new medicines will now require cabinet approval before they can be subsidised on the PBS[Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.read more »

Ways and means to lower lipids

Positive Living article • Adrian Ogier • 2 September 2010
symptoms, illnesses and opportunistic infections

The US Food and Drug Administration (FDAThe U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness(Of a drug or treatment). The maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the standard procedure, Phase II clinical trials gauge efficacy, and Phase III trials confirm it. of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation's blood supply. The Australian equivalent is the Therapeutic Goods Administration (TGA[Therapeutic Goods Administration] The federal government body that approves drugs and treatments before they can be prescribed.).) recently issued a warning to people taking the highest approved dose of simvastatin, a common cholesterolAn essential component of cell membranes and nerve fibre insulation, cholesterol is important for the metabolism and transport of fatty acids and the production of hormones and Vitamin D. Cholesterol is manufactured by the liverA large organ, located in the upper right abdomen, which assists in digestion by metabolising carbohydrates, fats and proteins, stores vitamins and minerals, produces amino acids, bile and cholesterol, and removes toxins from the blood., and is also present in certain foods. High blood cholesterol levels have been linked to heart disease and may be a side effectAn unwanted effect caused by the administration of drugs. Onset may be sudden or develop over time. of some anti-HIV medications.-lowering medication, that they have an increased risk of muscle injury compared to people taking lower doses of the drug. read more »

News from IAS 2010

Positive Living article • Adrian Ogier • 2 September 2010

Adrian Ogier gives a round up of treatments news from the Vienna Conference. read more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWA's work and be alerted to new content on the website by following @napwa.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.